Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 6:45 AM GMTVenclexta/Venclyxto is being developed by AbbVie and Roche.
FDA approves new blood cancer treatment from Pfizer Medical Dialogues Bureau22 Nov 2018 3:45 AM GMTThe U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...